Indoco Remedies Limited (INDOCO.NS) Stock Overview
Explore Indoco Remedies Limited’s financial performance, market position, analyst ratings, and future outlook.
Indoco Remedies Limited (INDOCO.NS)
Key Financials
Key Financials
Market Cap
22.9B
P/E Ratio
-23.10
EPS (TTM)
$-14.07
ROE
-0.10%
INDOCO.NS Stock Analysis & Investment Overview (NSE)
Our AI-powered analysis of Indoco Remedies Limited (NSE: INDOCO.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Indoco Remedies Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INDOCO.NS on the NSE shows an RSI of 55.62, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $240.19 for the NSE listing.
Key metrics behind Indoco Remedies Limited's NSE-traded stock include a P/E ratio of -23.10 and a market capitalization of 22.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of INDOCO.NS on the NSE.